PCR产物的RFLP分析在黄芪亚族（豆科）系统学研究中的应用初探

用聚合酶链式反应（ＰＣＲ）将豆科黄芪亚族７属９种及甘草亚族１属１种植物叶绿体基因组中ｎｄｈＦ和ｐｓｂＡ基因中一段约３．１ｋｂ的ＤＮＡ扩增出来,并摸索出一最佳的ＰＣＲ条件,使得此条带得以特异性扩增,可直接用于限制性内切酶水解。通过对此扩增片段的限制性片段长度多态性（ＲＦＬＰ）的初步分析,认为利用ＰＣＲ扩增出的ＤＮＡ进行ＲＦＬＰ分析来探讨植物的系统进化问题在中国现行条件下大有潜力,其方法简单易行,结果     

胡子鲇mtDNA多态性及限制性酶切图谱

用８种限制性内切酶对胡子鲇（ＣｌａｒｉａｓｆｕｓｃｕｓＬａｃｅｐｅｄｅ）肝脏线粒体ＤＮＡ（ＭｉｔｏｃｈｏｎｄｒｉａｌＤＮＡ,ｍｔＤＮＡ）进行了分析。ＸｈｏⅠ、ＥｃｏＲⅠ、ＰｓｔⅠ、ＢａｍＨⅠ、ＸｂａⅠ、ＨｉｎｄⅢ在ｍｔＤＮＡ分子上分别有２、３、１、１、３和５个切点。胡子鲇种内存在ｍｔＤＮＡ酶切片段长度多态性（Ｒｅｓｔｒｉｃｔｉｏｎｆｒａｇｍｅｎｔｌｅｎｇｔｈｐｏｌｙｍｏｒｐｈｉｓｍｓ,ＲＦＬＰ）。经ＢｇｌⅠ、ＢｇｌⅡ酶解,ｍｔＤＮＡ都出现两种酶切类型,Ⅰ型各具２个片段,Ⅱ型各具１个片段。ｍｔＤＮＡ分子量为１０．２４２×１０６ｕ,长度约为１６．６８ｋｂ。用双酶解法建立了胡子鲇ｍｔＤＮＡ的限制性酶切图谱,并对ＲＦＬＰ现象进行了分析。     

AFLP标记及在植物中的应用

ＡＦＬＰ是 1 992年由荷兰Ｋｅｙｇｅｎｅ公司Ｚａｂｅａｕ、Ｖｏｓ在ＰＣＲ和ＲＦＬＰ的基础上发展起来的一种检测ＤＮＡ多态性的新方法[1] ,并于1 993年获得欧洲专利局专利。与ＲＦＬＰ类似 ,ＡＦＬＰ也是通过限制性内切酶片段的不同长度检测ＤＮＡ多态性的一种ＤＮＡ分子标记技术。由于ＲＦＬＰ是以传统的Ｓｏｕｔｈｅｒｎ杂交为基础的 ,操作繁琐 ,对ＤＮＡ多态性的检出的灵敏度不高 ,在连锁图上有很多大的空间区。随着ＰＣＲ技术广泛应用 ,对分子标记技术的发展产生了巨大的推动作用。除了ＲＦＬＰ(限制性内切酶酶切片段长度多态性标记 …     

AFLP标记在果树遗传育种研究中的应用

1993年 ,Ｚａｂｅａｕ等发明了一项专利技术 ,扩增片段长度多态性 (ａｍｐｌｉｆｉｅｄｆｒａｇｍｅｎｔｌｅｎｇｔｈｐｏｌｙｍｏｒｐｈｉｓｍ ,ＡＦＬＰ) ,该技术结合了ＲＦＬＰ技术和ＰＣＲ技术的优点 ,以其高效性和高重复性等特点 ,被广泛应用于多种植物的遗传育种研究。1 .ＡＦＬＰ技术的原理和特点ＡＦＬＰ技术是基于对限制性片段的选择性扩增 ,基因组ＤＮＡ被限制性内切酶切割后 ,将限制性片段末端连上双链接头 ,根据接头序列和相邻的限制性位点序列设计引物对限制性片段进行扩增。扩增产物经电泳检测后再比较其谱带的差异。ＡＦＬＰ…     

板齿鼠线粒体DNA的研究

本文应用ＡｐａＩ、ＢａｍＨＩ、ＢｃｌＩ、ＢｇｌＩ、ＣｌａＩ、ＥｃｏＲＩ、ＥｃｏＲＶ、ＨｉｎｄＩＩ、ＰｓｔＩ、ＰｖｕＩＩ、ＳａｃＩ、ＳｃａＩ和ＸｂａＩ等１３种限制性内切酶对板齿鼠线粒体ＤＮＡ（ｍｔＤＮＡ）进行限制性片段长度多态（ＲＦＬＰ）分析,并用双酶解法构建其限制性内切酶图谱。结果表明板齿鼠存在３种ｍｔＤＮＡ单倍型,可通过限制酶ＰｖｕＩＩ、ＨｉｎｄＩＩ和ＡｐａＩ区分,呈现ＤＮＡ多态性和种内遗传变异。与小家鼠、褐家鼠ｍｔＤＮＡ限制性片段的数据相比较,板齿鼠和这两种鼠ｍｔＤＮＡ存在明显差异。板齿鼠ｍｔＤＮＡ限制性内切酶图谱的建立,为进一步系统研究鼠科动物的遗传分化提供了依据。     

杉木叶绿体和线粒体遗传的研究

利用ＰＣＲ技术分别以亲本杉木（Ｃｕｎｎｉｎｇｈａｍｉａｌａｎｃｅｏｌａｔａ（Ｌａｍｂ．）Ｈｏｏｋ．）、柳杉（ＣｒｙｐｔｏｍｅｒｉａｆｏｒｔｕｎｅｉＨｏｏｉｂｒｅｎｋ）和杉木×柳杉杂种的总ＤＮＡ为模板,扩增了叶绿体ｔｒｎＬｔｒｎＦ和线粒体ＣｏｘⅢ基因片段,比较了这些扩增片段的限制性内切酶ＡｌｕⅠ,ＤｄｅⅠ,ＨｉｎｆⅠ,ＭｓｅⅠ和ＲｓａⅠ的酶切片段多态性,结果表明：Ｆ１代的叶绿体ＤＮＡ为母系遗传,而线粒体ＤＮＡ为父系遗传。杉木线粒体ＤＮＡ父系遗传方式与杉科其他植物一致,而叶绿体ＤＮＡ母系遗传则为在松柏类植物中首次发现。     

用分子生物学技术对草菇进行菌株鉴别

利用ＡＰ－ＰＣＲ和ＲＡＰＤ技术对三个草菇菌株进行鉴别,其结果与用草菇菌株Ｖ３４基因文库中的中等重复序列为探针进行限制性内切酶长度多态性分析（ＲＦＬＰ）,及对编码核糖体５．８ＳｒＲＮＡ的ＤＮＡ（ｒＤＮＡ）进行ＰＣＲ扩增后的产物进行限制性内切酶长主多态性分析（ＰＣＲ－ＲＦＬＰ）的结果相一致。这一结果显示出用这四种方法对草菇菌株进行鉴别具有相似的效果。同时用这四种方法构建的分子生物学标记显示出这三个菌株     

AFLP分子标记及其在植物育种上的应用

扩增酶切片段多态性（ＡｍｐｌｉｆｉｅｄＲｓｔｒｉｃｉｔｏｎｆｒａｇｍｅｎｔｐｏｌｙｍｏｒｐｈｉｓｍ,简称ＡＦＬＰ）是由Ｚａｂｅａｕ等１９９２年发明的一项新的ＤＮＡ指纹技术,它结合了ＲＦＬＰ和ＰＣＲ技术的特点,具有ＲＦＬＰ技术的可靠性和ＰＣＲ技术高效性,其基本原理是对基因组ＤＮＡ酶切片段的选择性扩增,ＡＦＬＰ扩增片段的谱带数取决于采用的内切酶及引物３′端选择碱基的种类数目和所研究基因组的复杂性,实验     

中国4个民族mtDNA D环多态性研究

本文利用聚合酶链反应限制性片长度多态性（ＰＣＲ－ＲＦＬＰ）方法,检测了３６名汉族,３０名达斡尔族,３２名鄂伦春族,３０名鄂温克族随机选择正常个体ｍｔＤｎＡ Ｄ环４６５ｂｐＤＮＡ片多性并加以比较。结果表明,ｍｔＤＮＡ Ｄ环该片段的ＲＦＬＰ分析共产生２７种限制性类型,计算出４个民族的ｍｔＤＮＡ Ｄ环平均核苷酸歧异频率,并对４个民族的亲缘关系进行了聚类分析。     

野大豆群体DNA随机扩增产物的限制性内切酶消化

为了提高ＲＡＰＤ方法检测野大豆群体ＤＮＡ多态性的能力,随机扩增产物用限制性内切酶消化,通过聚丙烯酰胺凝胶电泳分离后用银染法检测酶切产物。结果发现：１．有的限制性内切酶能够消化野大豆群体ＤＮＡ的随机扩增产物,有的却不能。２．有的限制性内切酶消化无ＲＡＰＤ个体的扩增产物后能够产生多太性ＤＮＡ片段,有 内切酶不能产生。３．有的引物的无ＲＡＰＤ个体的扩增产物经限制性内切酶消化后能够产生多态性的ＤＮＡ片会面     

两个猪瘟病毒野毒株gp55基因抗原编码区序列的分析及比较

利用反转录－PCR方法扩增了吉林省猪瘟病毒（HCV）两个野毒株gp55基因的主要保护性抗原编码区,并将其克隆到pGEM－T载体中,然后用Sanger双脱氧法测定了其核苷酸序列,并推导了其氨基酸序列。将测定的这两个HCV野毒株的部分序列（350bp）与国内外已知的HCV序列进行比较,结果表明：这两个野毒株的核苷酸序列的同源性为94．9％,氨基酸序列同源性为97．4％,与1985～1992年意大利中部分离4个野毒株的同源性明显高于其它HCV毒株,核苷酸同源性分别为97．2％～98．3％和94.0％～949％,氨基酸同源性分别为98．3％～991％和97.4％～98.3％,而与我国的HCV标准强毒株即石门株的核苷酸同源性仅分别为83.1％和83.1％,氨基酸同源性仅分别为90.6％和91.4％。因此认为吉林省这两个野毒株与意大利中部的4个野毒株具有密切的关系,而与石门株很可能来源不同。     

Detection of hepatitis C virus RNA in the hearts of patients with hepatogenic cardiomyopathy

We examined the Hepatitis C virus (HCV) genome in the myocardium and liver obtained at autopsy from seven patients with HCV-positive liver cirrhosis and hepatocellular carcinoma (HCC) by in situ hybridization and histopathological studies. The HCV virus genome was detected in the myocardium of one patient as well as in the liver in three out of seven patients. However, Epstein-Barr (EB) virus genome could not be detected in liver or myocardium. In the patient who showed positive reaction to HCV in myocardium, both serum HCV and Hepatitis B virus (HBV) antibodies were positive. It is unknown whether this was related to an immunological abnormality of the host or to an interaction between RNA and DNA viruses. In conclusion, we could identify the HCV genome in the myocardium of a patient with hepatogenic myocardosis.     

Identification of a novel sequence at the 3' end of the GB virus B genome

GB virus B (GBV-B) is a virus of the family Flaviviridae that infects small primates (Saguinus sp. [tamarins]) and shows similarities to hepatitis C virus (HCV) in genome organization, protein function, tissue tropism, and pathogenicity. This suggests the possibility of using tamarins infected by GBV-B or GBV-B/HCV chimeric viruses as a surrogate animal model of HCV infection. To achieve the construction of such chimeric viruses, it is essential to produce a complete and infectious GBV-B genomic RNA. We have identified a novel sequence at the 3' end of the GBV-B genome and show that it can be arranged in a secondary structure resembling that of the 3' end of the HCV genome, which is known to be essential for infectivity.     

Subgenomic replicon derived from a cell line infected with the hepatitis C virus

Recently, cell culture systems have been established, where a hepatitis C virus (HCV) subgenomic replicon was efficiently replicated and maintained for a long period. To see whether a HCV sequence derived from HCV-infected cultured cell sequence can be used for the construction of a functional replicon, a HCV subgenomic RNA carrying a neomycin-resistant gene was constructed using the HCV genome RNA obtained from cultured cells infected with HCV. After transfection, G418-resistant Huh-7 cells were selected and subcloned. Finally, the production of HCV proteins and de novo synthesis of subgenomic RNA were confirmed in the selected cell clone, indicating that this subgenomic RNA replicated in cultured cells and functioned as a replicon. These results suggest that the HCV genome obtained from an in vitro HCV infection system with cultured cells can be used to develop a subgenomic replicon system with diverse HCV sequences.     

Sequence analysis of the 5' non coding region of Turkish HCV isolates: implications for PCR diagnosis

Hepatitis C virus (HCV) is a positive-strand RNA virus related to pestiviruses and flaviviruses. The 5' noncoding region (NCR) of the virus genome consists of 324-341 nucleotides and is generally highly conserved among different HCV isolates which has made this region the choice for primer selection in amplification of HCV sequences by polymerase chain reaction (PCR). In this study, we report the partial nucleotide sequences of the 5'-NCR from type 1a (n = 4), type 1b (n = 6) and type 4 (n = 1) Turkish HCV isolates. Sequence information was obtained by direct sequencing of RT-PCR product using biotinylated primers and single strands were sequenced using T7 DNA polymerase after binding to streptavidin coated magnetic beads. In comparison to prototype type 1a consensus sequence, all type 1b sequences had A-G substitution at position - 99. Nucleotid changes from the prototype 1a sequence were found in 12 of the 174 nucleotide positions. The most variable domain spans 51 nucleotides (positions - 167 to - 117) where nine polymorphic sites were identified. Although the nucleotide sequence of the 5'-noncoding region is highly conserved there are type-specific polymorphic sites within this region that has to be taken into consideration in the design of oligonucleotide primers for reliable amplification of sequences from different HCV genotypes.     

Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly

Persistent infection with the hepatitis C virus (HCV) is a major risk factor for the development of liver cirrhosis and hepatocellular carcinoma. With an estimated about 3% of the world population infected with this virus, the lack of a prophylactic vaccine and a selective therapy, chronic hepatitis C currently is a main indication for liver transplantation. The establishment of cell-based replication and virus production systems has led to first insights into the functions of HCV proteins. However, the role of nonstructural protein 5A (NS5A) in the viral replication cycle is so far not known. NS5A is a membrane-associated RNA-binding protein assumed to be involved in HCV RNA replication. Its numerous interactions with the host cell suggest that NS5A is also an important determinant for pathogenesis and persistence. In this study we show that NS5A is a key factor for the assembly of infectious HCV particles. We specifically identify the C-terminal domain III as the primary determinant in NS5A for particle formation. We show that both core and NS5A colocalize on the surface of lipid droplets, a proposed site for HCV particle assembly. Deletions in domain III of NS5A disrupting this colocalization abrogate infectious particle formation and lead to an enhanced accumulation of core protein on the surface of lipid droplets. Finally, we show that mutations in NS5A causing an assembly defect can be rescued by trans-complementation. These data provide novel insights into the production of infectious HCV and identify NS5A as a major determinant for HCV assembly. Since domain III of NS5A is one of the most variable regions in the HCV genome, the results suggest that viral isolates may differ in their level of virion production and thus in their level of fitness and pathogenesis.     

Generation of a recombinant reporter hepatitis C virus useful for the analyses of virus entry, intra-cellular replication and virion production

The lack of a culture system that efficiently produces progeny virus has hampered hepatitis C virus (HCV) research. Recently, the discovery of a novel HCV isolate JFH1 and its chimeric derivative J6/JFH1 has led to the development of an efficient virus productive culture system. To construct an easy monitoring system for the viral life cycle of HCV, we generated bicistronic luciferase reporter virus genomes based on the JFH1 and J6/JFH1 isolates, respectively. Transfection of the J6/JFH1-based reporter genome to Huh7.5 cells produced significantly greater levels of progeny virus than transfection of the JFH1 genome. Furthermore, the expression of dominant-negative Vps4, a key molecule of the endosomal sorting complex required for transport machinery, inhibited the virus production of JFH1, but not that of J6/JFH1. These results may account for the different abilities to produce progeny virus between JFH1 and J6/JFH1. Using the J6/JFH1/Luc system, we showed that the two polyanions heparin and polyvinyl sulfate decreased the infectivity of J6/JFH1/Luc virus in a dose-dependent manner. We also analyzed the function of microRNA on HCV replication and found that miR-34b could affect the replication of HCV. The reporter virus generated in this study will be useful for investigating the nature of the HCV life cycle and for identification of HCV inhibitors.     

Computational reconstruction of Bole1a, a representative synthetic hepatitis C virus subtype 1a genome

Hepatitis C virus (HCV) research is hampered by the use of arbitrary representative isolates in cell culture and immunology. The most replicative isolate in vitro is a subtype 2a virus (JFH-1); however, genotype 1 is more prevalent worldwide and represents about 70% of infections in the United States, and genotypes differ from one another by 31% to 33% at the nucleotide level. For phylogenetic and immunologic analyses, viruses H77 and HCV-1 (both subtype 1a) are commonly used based on their historic importance. In an effort to rationally design a representative subtype 1a virus (Bole1a), we used Bayesian phylogenetics, ancestral sequence reconstruction, and covariance analysis on a curated set of 390 full-length human HCV 1a sequences from GenBank. By design, Bole1a contains variations present in widely circulating strains and matches more epitope-sized peptides in a full-genome comparison to subtype 1a isolates than any other sequence studied. Parallel analyses confirm that selected epitopes from the Bole1a genome were able to elicit a robust T cell response. In a proof of concept for infectivity, the envelope genes (E1 and E2) of Bole1a were expressed in an HIV pseudoparticle system containing HCV envelope genes and HIV nonenvelope genes with luciferase expression. The resulting Bole1a pseudoparticle robustly infected Hep3B cells. In this study, we demonstrate that a rationally designed, fully synthetic HCV genome contains representative epitopes and envelope genes that assemble properly and mediate entry into target cells.     

Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect

Hepatitis C virus (HCV) is a major cause of cirrhosis and hepatocellular carcinoma. Interferon alone or together with ribavirin is the only therapy for HCV infection; however, a significant number of HCV-infected individuals do not respond to this treatment. Therefore, the development of new therapeutic options against HCV is a matter of urgency. In the present study, we have examined vectors carrying short hairpin RNA (shRNA) targeting the 5' nontranslated conserved region of the HCV genome for inhibition of virus replication. Initially, three sequences were selected, and all three shRNAs (psh-53, psh-274, and psh-375) suppressed HCV internal ribosome entry site (IRES)-mediated translation to different degrees in Huh-7 cells. Next, we introduced siRNA into Huh-7.5 cells persistently infected with HCV genotype 2a (JFH1). The most efficient inhibition of JFH1 replication was observed with psh-274, targeted to the portion from subdomain IIId to IIIe of the IRES. Subsequently, Huh-7.5 cells stably expressing psh-274 further displayed a significant reduction in HCV JFH1 replication. The effect of psh-274 on cell-culture-grown HCV genotype 1a (H77) was also evaluated, and inhibition of virus replication and infectivity titers was observed. In the absence of a cell-culture-grown HCV genotype 1b, the effects of psh-274 on subgenomic and full-length replicons were examined, and efficient inhibition of genome replication was observed. Therefore, we have identified a conserved sequence targeted to the HCV genome that can inhibit replication of different genotypes, suggesting the potential of siRNA as an additional therapeutic modality against HCV infection.